Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.559
+0.039 (1.12%)
Mar 14, 2025, 11:29 AM EDT - Market open
Iovance Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,167 | 2,255 | 2,081 | 1,009 | 2,995 | 6,806 | |
| Market Cap Growth | 8.40% | 8.40% | 106.29% | -66.33% | -55.99% | 94.85% | |
| Enterprise Value | 889 | 1,937 | 1,799 | 729 | 2,491 | 6,103 | |
| Last Close Price | 3.52 | 7.40 | 8.13 | 6.39 | 19.09 | 46.40 | |
| PS Ratio | 6.22 | 13.75 | 1749.89 | - | - | - | |
| PB Ratio | 1.51 | 3.17 | 3.56 | 2.02 | 4.82 | 10.37 | |
| P/TBV Ratio | 5.27 | 5.27 | 5.86 | 2.02 | 4.82 | 10.37 | |
| EV/Sales Ratio | 5.42 | 11.80 | 1512.80 | - | - | - | |
| Debt / Equity Ratio | 0.08 | 0.08 | 0.13 | 0.17 | 0.12 | 0.08 | |
| Asset Turnover | 0.19 | 0.19 | 0.00 | - | - | - | |
| Inventory Turnover | 4.01 | 4.01 | - | - | - | - | |
| Quick Ratio | 3.21 | 3.21 | 2.54 | 5.16 | 5.65 | 11.47 | |
| Current Ratio | 3.74 | 3.74 | 2.79 | 5.24 | 5.69 | 11.59 | |
| Return on Equity (ROE) | -57.48% | -57.48% | -81.91% | -70.61% | -53.55% | -54.34% | |
| Return on Assets (ROA) | -29.22% | -29.22% | -39.86% | -34.59% | -27.71% | -29.41% | |
| Return on Capital (ROIC) | -34.57% | -34.57% | -46.22% | -39.01% | -30.57% | -32.14% | |
| Earnings Yield | -32.25% | -16.50% | -21.34% | -39.25% | -11.43% | -3.81% | |
| FCF Yield | -31.54% | -16.14% | -18.46% | -31.05% | -8.86% | -3.70% | |
| Buyback Yield / Dilution | -23.28% | -23.28% | -47.64% | -3.82% | -10.92% | -11.23% | |
| Total Shareholder Return | -23.28% | -23.28% | -47.64% | -3.82% | -10.92% | -11.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.